Skip to main content
Premium Trial:

Request an Annual Quote

PathogenDx, Nationwide Laboratory Services Partner on Fungal Testing

NEW YORK – PathogenDx has entered into a strategic partnership with Nationwide Laboratory Services for fungal testing of dermatology and podiatry samples.

The PathogenDx has developed an array-based system that can be used for different applications, with the firm initially targeting the cannabis testing space.

Nationwide Laboratory Services will now create a laboratory developed test using the PathogenDx testing technology, with aims for a multiplex fungal assay to identify up to 44 different pathogens at a time. The firms expect the assay to be ready for beta testing by the first quarter of 2020, according to a statement.

The industry standard for fungal testing in dermatology and podiatry is more than 72 hours turnaround time. The new test "will offer doctors, patients and insurers ultra-rapid and less expensive fungal testing results in 6 hours or less," said PathogenDx CEO Milan Patel.

Nationwide Laboratory Services is a full-service diagnostic laboratory based in South Florida. It is in-network with more than 100 insurance plans with a number of patient service centers throughout the US, particularly in the Southeast.

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.